INVA
NASDAQ
$21.28
Innoviva Inc (INVA)
Innoviva, Inc. is dedicated to the development and commercialization of pharmaceutical products. The company is headquartered in Burlingame, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $35.50 (+66.82%)
Market Cap
$1.62B
PEG Ratio
0.32
Profit Margin
119.9%
P/E Ratio
3.15
Price Chart
Valuation
Market Cap$1.62B
P/E3.15
Forward P/E11.07
PEG0.32
P/S3.81
P/B1.22
Profitability
Total Revenue (TTM)$421M
Gross Profit (TTM)$312M
EBITDA$617M
Profit Margin119.9%
Operating Margin38.9%
EPS$6.94
Financial Health
Debt-to-Equity19.2%
Free Cash Flow Yield11.26%
Growth & Risk
EPS 5Y CAGR+16.74%
Revenue 5Y CAGR+4.13%
FCF 5Y CAGR-10.88%
Beta (5Y)0.15
Sharpe Ratio0.25